Recent federal actions under the Controlled Substances Act have advanced marijuana rescheduling through executive and administrative channels. In April 2026, the Department of Justice and DEA issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, effective late that month, while launching an expedited hearing process for broader changes. This followed a December 2025 presidential executive order directing rapid completion of the rulemaking originally proposed in 2024. The DEA hearing, set to begin June 29 and conclude by mid-July 2026, will evaluate evidence on shifting all forms of marijuana from Schedule I, with traders closely tracking procedural milestones, agency statements, and any shifts in legislative or judicial timelines that could accelerate or delay full implementation.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado$758,943 Vol.
31 mar 2026
30 de junio
2%
31 de diciembre
24%
$758,943 Vol.
30 de junio
$337,208 Vol.
2%
31 de diciembre
$156,853 Vol.
24%
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.Recent federal actions under the Controlled Substances Act have advanced marijuana rescheduling through executive and administrative channels. In April 2026, the Department of Justice and DEA issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, effective late that month, while launching an expedited hearing process for broader changes. This followed a December 2025 presidential executive order directing rapid completion of the rulemaking originally proposed in 2024. The DEA hearing, set to begin June 29 and conclude by mid-July 2026, will evaluate evidence on shifting all forms of marijuana from Schedule I, with traders closely tracking procedural milestones, agency statements, and any shifts in legislative or judicial timelines that could accelerate or delay full implementation.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Mercado abierto: Feb 7, 2026, 5:04 PM ET
Volumen
$758,943Fecha de finalización
31 mar 2026Mercado abierto
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.Recent federal actions under the Controlled Substances Act have advanced marijuana rescheduling through executive and administrative channels. In April 2026, the Department of Justice and DEA issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, effective late that month, while launching an expedited hearing process for broader changes. This followed a December 2025 presidential executive order directing rapid completion of the rulemaking originally proposed in 2024. The DEA hearing, set to begin June 29 and conclude by mid-July 2026, will evaluate evidence on shifting all forms of marijuana from Schedule I, with traders closely tracking procedural milestones, agency statements, and any shifts in legislative or judicial timelines that could accelerate or delay full implementation.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Volumen
$758,943Fecha de finalización
31 mar 2026Mercado abierto
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...Recent federal actions under the Controlled Substances Act have advanced marijuana rescheduling through executive and administrative channels. In April 2026, the Department of Justice and DEA issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, effective late that month, while launching an expedited hearing process for broader changes. This followed a December 2025 presidential executive order directing rapid completion of the rulemaking originally proposed in 2024. The DEA hearing, set to begin June 29 and conclude by mid-July 2026, will evaluate evidence on shifting all forms of marijuana from Schedule I, with traders closely tracking procedural milestones, agency statements, and any shifts in legislative or judicial timelines that could accelerate or delay full implementation.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes